Karim SM, Adaikan PG, Lau LC, Tai MY. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
PROSTAGLANDINS AND MEDICINE 1981;
6:521-7. [PMID:
7022510 DOI:
10.1016/0161-4630(81)90112-9]
[Citation(s) in RCA: 16] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Intravenous infusion of carboprostacyclin, a chemically stable analogue of prostacyclin (PGI2) resulted in ex-vivo inhibition of ADP-induced platelet aggregation at doses that did not produce significant changes in blood pressure or heart rate. Oral administration of relatively large doses of this compound also inhibited ex-vivo ADP-induced platelet aggregation but this was accompanied by headache, facial flush, tachycardia and changes in blood pressure.
Collapse